Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type

American Journal of Surgical Pathology

Volumn 36, Issue 5, 2012, Pages 688-695

  Cuff, Justin ^a   Longacre, Teri A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

endometriosis; endometriosis associated carcinoma; ovarian cancer; ovarian clear cell carcinoma; ovarian endometrioid carcinoma

Indexed keywords

ADENOCARCINOMA; ADULT; AGE; AGED; ARTICLE; CANCER STAGING; DISEASE COURSE; DISEASE FREE SURVIVAL; ENDOMETRIOID CARCINOMA; ENDOMETRIOSIS; FEMALE; FOLLOW UP; HUMAN; MIDDLE AGED; MORTALITY; MULTIPLE CANCER; OVARY TUMOR; PATHOLOGY; PROGNOSIS; SURVIVAL;

ADENOCARCINOMA, CLEAR CELL; ADULT; AGE FACTORS; AGED; CARCINOMA, ENDOMETRIOID; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; ENDOMETRIOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; OVARIAN NEOPLASMS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84859885981     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31824b6eed     Document Type: Article

References (24)

1. Aris A. Endometriosis-associated ovarian cancer: a ten-year cohort study of women living in the Estrie Region of Quebec, Canada. J Ovarian Res. 2010;3:2.
2. Bell KA, Kurman RJ. A clinicopathologic analysis of atypical proliferative (borderline) tumors and well-differentiated endometrioidadenocarcinomas of the ovary. Am J Surg Pathol. 2000;24: 1465-1479.
3. Brinton LA, Gridley G, Persson I, et al. Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol. 1997; 176:572-579. (Pubitemid 27147164)
4. Czernobilsky B, Silverman BB, Enterline HT. Clear-cell carcinoma of the ovary. A clinicopathologic analysis of pure and mixed forms and comparison with endometrioid carcinoma. Cancer. 1970;25: 762-772.
5. Czernobilsky B, Silverman BB, Mikuta JJ. Endometrioid carcinoma of the ovary. A clinicopathologic study of 75 cases. Cancer. 1970; 26:1141-1152.
6. DeLair D, Oliva E, Kobel M, et al. Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases. Am J Surg Pathol. 2011;35:36-44.
7. Eifel P, Hendrickson M, Ross J, et al. Simultaneous presentation of carcinoma involving the ovary and the uterine corpus. Cancer.1982;50:163-170. (Pubitemid 12084872)
8. Erzen M, Rakar S, Klancnik B, et al. Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study. Gynecol Oncol. 2001;83:100-108. (Pubitemid 32959885)
9. Giudice LC, Kao LC. Endometriosis. Lancet. 2004;364:1789-1799. (Pubitemid 39488065)
10. Goff BA, Sainz de la Cuesta R, Muntz HG, et al. Clear cell carcinoma of the ovary: a distinct histologic type with poorprognosis and resistance to platinum-based chemotherapy in stage III disease. Gynecol Oncol. 1996;60:412-417. (Pubitemid 26077628)
11. Komiyama S, Aoki D, Tominaga E, et al. Prognosis of Japanese patients with ovarian clear cell carcinoma associated with pelvic endometriosis: clinicopathologic evaluation. Gynecol Oncol. 1999; 72:342-346. (Pubitemid 29118191)
12. Kumar S, Munkarah A, Arabi H, et al. Prognostic analysis of ovarian cancer associated with endometriosis. Am J Obstet Gynecol.2011;204:63e1-7.
13. Kurian AW, Balise RR, McGuire V, et al. Histologic types of epithelial ovarian cancer: have they different risk factors? Gynecol Oncol. 2005;96:520-530. (Pubitemid 40127159)
14. Kurman RJ, Craig JM. Endometrioid and clear cell carcinoma of the ovary. Cancer. 1972;29:1653-1664.
15. Lauchlan SC. Conceptual unity of the Mullerian tumor group. A histologic study. Cancer. 1968;22:601-610.
16. McMeekin DS, Burger RA, Manetta A, et al. Endometrioid adenocarcinoma of the ovary and its relationship to endometriosis.Gynecol Oncol. 1995;59:81-86.
17. Modesitt SC, Tortolero-Luna G, Robinson JB, et al. Ovarian and extraovarian endometriosis-associated cancer. Obstet Gynecol. 2002; 100:788-795. (Pubitemid 35300039)
18. Nagle CM, Olsen CM, Webb PM, et al. Endometrioid and clear cell ovarian cancers: a comparative analysis of risk factors. Eur J Cancer. 2008;44:2477-2484.
19. Ogawa S, Kaku T, Amada S, et al. Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study. Gynecol Oncol. 2000;77:298-304. (Pubitemid 30317153)
20. Orezzoli JP, Russell AH, Oliva E, et al. Prognostic implication of endometriosis in clear cell carcinoma of the ovary. Gynecol Oncol. 2008;110:336-344.
21. Somigliana E, Vigano P, Parazzini F, et al. Association between endometriosis and cancer: a comprehensive review and a critical analysis of clinical and epidemiological evidence. Gynecol Oncol. 2006;101:331-341. (Pubitemid 44262088)
22. Steed H, Chapman W, Laframboise S. Endometriosis-associated ovarian cancer: a clinicopathologic review. J Obstet Gynaecol Can. 2004;26:709-715.
23. Van Gorp T, Amant F, Neven P, et al. Endometriosis and the development of malignant tumours of the pelvis. A review of literature. Best Pract Res Clin Obstet Gynaecol. 2004;18:349-371. (Pubitemid 38786637)
24. Willner J, Wurz K, Allison KH, et al. Alternate molecular genetic pathways in ovarian carcinomas of common histological types. HumPathol. 2007;38:607-613. (Pubitemid 46399888)